Evidence map›Paper›PMID 28912718›Full record

ReviewFrontiers in pharmacology2017

Technical Improvement and Application of Hydrodynamic Gene Delivery in Study of Liver Diseases.

Mei Huang, Rui Sun, Qiang Huang, Zhigang Tian

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in pharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Precision models in hepatocellular carcinoma.Nature reviews. Gastroenterology & hepatology · 2025
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. A review of the tortuous path of nonviral gene delivery and recent progress.International journal of biological macromolecules · 2021
    Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Intravenous Delivery ofInternational journal of molecular sciences · 2018
    Article
  16. Nonviral Gene Therapy for Cancer: A Review.Diseases (Basel, Switzerland) · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Mei HuangAnhui Province Key Laboratory of Hepatopancreatobiliary Surgery, Department of General Surgery, Anhui Provincial Hospital Affiliated with Anhui Medical UniversityHefei, China.
Rui SunInstitute of Immunology, School of Life Sciences and Medical Center, University of Science and Technology of ChinaHefei, China.
Qiang HuangAnhui Province Key Laboratory of Hepatopancreatobiliary Surgery, Department of General Surgery, Anhui Provincial Hospital Affiliated with Anhui Medical UniversityHefei, China.
Zhigang TianInstitute of Immunology, School of Life Sciences and Medical Center, University of Science and Technology of ChinaHefei, China.
Anhui Provincial Hospital · CNUniversity of Science and Technology of China · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Development of an safe and efficient

Indexed as

gene deliverygene therapyHBVhydrodynamic injectionliver diseases

Identifiers

PMID28912718
PMCPMC5582077
OpenAlexW2752211890

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.